Standard
Angiotensinogen promoter methylation to predict bevacizumab response in recurrent glioblastoma patients. / Urup, Thomas; Gillberg, Linn; Kaastrup, Katja; Lu, Maja Schuang; Michaelsen, Signe Regner; Larsen, Vibeke A.; Christensen, Ib Jarle; Broholm, Helle; Lassen, Ulrik; Gronbaek, Kirsten; Poulsen, Hans Skovgaard.
I:
Neuro-Oncology, Bind 21, Nr. Supplement 6, 2019, s. vi149.
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt
Harvard
Urup, T
, Gillberg, L, Kaastrup, K, Lu, MS
, Michaelsen, SR, Larsen, VA, Christensen, IJ, Broholm, H
, Lassen, U, Gronbaek, K & Poulsen, HS 2019, '
Angiotensinogen promoter methylation to predict bevacizumab response in recurrent glioblastoma patients',
Neuro-Oncology, bind 21, nr. Supplement 6, s. vi149.
https://doi.org/10.1093/neuonc/noz175.624APA
Urup, T.
, Gillberg, L., Kaastrup, K., Lu, M. S.
, Michaelsen, S. R., Larsen, V. A., Christensen, I. J., Broholm, H.
, Lassen, U., Gronbaek, K., & Poulsen, H. S. (2019).
Angiotensinogen promoter methylation to predict bevacizumab response in recurrent glioblastoma patients.
Neuro-Oncology,
21(Supplement 6), vi149.
https://doi.org/10.1093/neuonc/noz175.624Vancouver
Urup T
, Gillberg L, Kaastrup K, Lu MS
, Michaelsen SR, Larsen VA o.a.
Angiotensinogen promoter methylation to predict bevacizumab response in recurrent glioblastoma patients.
Neuro-Oncology. 2019;21(Supplement 6):vi149.
https://doi.org/10.1093/neuonc/noz175.624Author
Urup, Thomas ; Gillberg, Linn ; Kaastrup, Katja ; Lu, Maja Schuang ; Michaelsen, Signe Regner ; Larsen, Vibeke A. ; Christensen, Ib Jarle ; Broholm, Helle ; Lassen, Ulrik ; Gronbaek, Kirsten ; Poulsen, Hans Skovgaard. / Angiotensinogen promoter methylation to predict bevacizumab response in recurrent glioblastoma patients. I: Neuro-Oncology. 2019 ; Bind 21, Nr. Supplement 6. s. vi149.
Bibtex
@article{d5eb9d54ca3c4aabbea8bcaa071c275f,
title = "Angiotensinogen promoter methylation to predict bevacizumab response in recurrent glioblastoma patients",
author = "Thomas Urup and Linn Gillberg and Katja Kaastrup and Lu, {Maja Schuang} and Michaelsen, {Signe Regner} and Larsen, {Vibeke A.} and Christensen, {Ib Jarle} and Helle Broholm and Ulrik Lassen and Kirsten Gronbaek and Poulsen, {Hans Skovgaard}",
year = "2019",
doi = "10.1093/neuonc/noz175.624",
language = "English",
volume = "21",
pages = "vi149",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "Supplement 6",
}
RIS
TY - ABST
T1 - Angiotensinogen promoter methylation to predict bevacizumab response in recurrent glioblastoma patients
AU - Urup, Thomas
AU - Gillberg, Linn
AU - Kaastrup, Katja
AU - Lu, Maja Schuang
AU - Michaelsen, Signe Regner
AU - Larsen, Vibeke A.
AU - Christensen, Ib Jarle
AU - Broholm, Helle
AU - Lassen, Ulrik
AU - Gronbaek, Kirsten
AU - Poulsen, Hans Skovgaard
PY - 2019
Y1 - 2019
U2 - 10.1093/neuonc/noz175.624
DO - 10.1093/neuonc/noz175.624
M3 - Conference abstract in journal
VL - 21
SP - vi149
JO - Neuro-Oncology
JF - Neuro-Oncology
SN - 1522-8517
IS - Supplement 6
ER -
